Tags

Type your tag names separated by a space and hit enter

[Extracorporeal shock wave therapy for Peyronie's disease].
Prog Urol. 2020 Sep; 30(10):488-499.PU

Abstract

INTRODUCTION

The efficiency of extracorporeal shock waves (SW) for Peyronie's disease (PD) is controversial.

METHODS

A systematic review of the literature published between 2000 and 2019 was conducted using the PRISMA methodology. We used Medline data with the following.

KEYWORDS

"extracorporeal shock wave therapy" ; "Peyronie's disease"; "Sexuality"; Penile erection.

RESULTS

Thirteen articles were selected. Our review showed that SW were beneficial in terms of pain. Regarding plaques size and penile curvature, the results remain divergent.

CONCLUSION

SW may be useful in the management of pain in selected patients with PD. Its effectiveness on plaques size and penile curvature needs to be demonstrated through controlled and randomized trials. The population has to be targeted, and the treatment protocol must also be standardized.

Authors+Show Affiliations

Sorbonne Université, GRC 5 Predictive Onco-Uro, AP-HP, Urologie, Pitie-Salpétrière, 75013 Paris, France.Sorbonne Université, GRC 5 Predictive Onco-Uro, AP-HP, Urologie, Pitie-Salpétrière, 75013 Paris, France.Centre d'urologie du Polygone, les bureaux du Polygone, Montpellier, France.Service d'urologie, clinique Pasteur, Toulouse, France.Sorbonne Université, GRC 5 Predictive Onco-Uro, AP-HP, Urologie, Pitie-Salpétrière, 75013 Paris, France. Electronic address: morgan.roupret@aphp.fr.

Pub Type(s)

Journal Article
Systematic Review

Language

fre

PubMed ID

32370921

Citation

Ochoa, A, et al. "[Extracorporeal Shock Wave Therapy for Peyronie's Disease]." Progres En Urologie : Journal De l'Association Francaise D'urologie Et De La Societe Francaise D'urologie, vol. 30, no. 10, 2020, pp. 488-499.
Ochoa A, Guillot-Tantay C, Faix A, et al. [Extracorporeal shock wave therapy for Peyronie's disease]. Prog Urol. 2020;30(10):488-499.
Ochoa, A., Guillot-Tantay, C., Faix, A., Misrai, V., & Rouprêt, M. (2020). [Extracorporeal shock wave therapy for Peyronie's disease]. Progres En Urologie : Journal De l'Association Francaise D'urologie Et De La Societe Francaise D'urologie, 30(10), 488-499. https://doi.org/10.1016/j.purol.2020.04.003
Ochoa A, et al. [Extracorporeal Shock Wave Therapy for Peyronie's Disease]. Prog Urol. 2020;30(10):488-499. PubMed PMID: 32370921.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Extracorporeal shock wave therapy for Peyronie's disease]. AU - Ochoa,A, AU - Guillot-Tantay,C, AU - Faix,A, AU - Misrai,V, AU - Rouprêt,M, Y1 - 2020/05/01/ PY - 2019/12/31/received PY - 2020/03/31/revised PY - 2020/04/03/accepted PY - 2020/5/7/pubmed PY - 2021/9/3/medline PY - 2020/5/7/entrez KW - Extracorporeal shock wave therapy KW - Lithotritie extracorporelle KW - Maladie de Lapeyronie KW - Penile erection KW - Peyronie's disease KW - Sexuality KW - Sexualité KW - Érection SP - 488 EP - 499 JF - Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie JO - Prog Urol VL - 30 IS - 10 N2 - INTRODUCTION: The efficiency of extracorporeal shock waves (SW) for Peyronie's disease (PD) is controversial. METHODS: A systematic review of the literature published between 2000 and 2019 was conducted using the PRISMA methodology. We used Medline data with the following. KEYWORDS: "extracorporeal shock wave therapy" ; "Peyronie's disease"; "Sexuality"; Penile erection. RESULTS: Thirteen articles were selected. Our review showed that SW were beneficial in terms of pain. Regarding plaques size and penile curvature, the results remain divergent. CONCLUSION: SW may be useful in the management of pain in selected patients with PD. Its effectiveness on plaques size and penile curvature needs to be demonstrated through controlled and randomized trials. The population has to be targeted, and the treatment protocol must also be standardized. SN - 1166-7087 UR - https://wwww.unboundmedicine.com/medline/citation/32370921/[Extracorporeal_shock_wave_therapy_for_Peyronie's_disease]_ DB - PRIME DP - Unbound Medicine ER -